Enzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — For patients with prostate cancer with high-risk biochemical recurrence, enzalutamide plus leuprolide is best for metastasis-free survival, according to a study published in the Oct. 19 issue of the New Eng…
Learn MoreFDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — The U.S. Food and Drug Administration has proposed a ban on the use of formaldehyde in hair relaxers over concerns about its link to respiratory problems and certain cancers. Right now, the FDA only discour…
Learn MoreLa FDA se apresta a prohibir los cigarrillos mentolados y los puros saborizados
MIÉRCOLES 18 de octubre de 2023 (HealthDay News)- – Una norma propuesta por reguladores federales que prohibiría los cigarrillos mentolados y los puros saborizados ha sido enviada a la Oficina de Administración y Presupuesto de la Casa Blanca para su …
Learn MoreSelenium Not Linked to Recurrence of Non-Muscle-Invasive Bladder Cancer
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — For patients with non-muscle-invasive bladder cancer (NMIBC), selenium supplementation does not reduce the risk for recurrence, while vitamin E is associated with an increased risk for recurrence, according…
Learn MoreFDA Approves Nivolumab as Adjuvant Treatment for Melanoma
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Opdivo (nivolumab) for the adjuvant treatment of completely resected stage IIB/C melanoma in patients ages 12 years and older.The approval was based on res…
Learn MoreFDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — The U.S. Food and Drug Administration has proposed a ban on the use of formaldehyde in hair relaxers over concerns about its link to respiratory problems and certain cancers.Right now, the FDA only discoura…
Learn MoreObesity Raises Odds for Recurrence in Breast Cancer Survivors
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs may be less effective in women who are obese.Breast cancer cells in …
Learn MoreSeniors, 18 Holes of Golf Might Make You Smarter
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — Want to do something to protect your thinking skills as you age? Swing that golf club or go for a walk.A new study found that walking about 3.7 miles or playing 18 holes of golf improved cognitive function….
Learn MoreBlood Pressure’s Ups & Downs Could Harm Heart, Brain
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — Fluctuating blood pressure can be a harbinger for both dementia and heart disease, a new study finds.Ups and downs within 24 hours or even over several days or weeks were linked with impaired thinking, rese…
Learn MoreA Doctor’s Empathy Can Be Key to Breast Cancer Care
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — A breast cancer diagnosis often causes anxiety and depression, but an empathetic doctor can help.Supportive communication is key to reducing patient uncertainty and promoting mental well-being, Rutgers Univ…
Learn More